IP vs IPSC · P/E 43, $26.62B cap vs rev $6.6M
International Paper (IP) versus Century Therapeutics Inc (IPSC) — a side-by-side from cached financials, not a winner call.
International Paper (IP) is a packaging & containers company listed on US.
Century Therapeutics Inc (IPSC) is a biotechnology company listed on US.
IP does not have a complete income-statement cache yet.
Latest reported IPSC revenue for 2024-12-31 was $6.6M. Net income was -$126.6M. Revenue was up 194.8% from 2023-12-31 to 2024-12-31. IPSC currently screens at market cap $47.8M.
IP currently screens at market cap $26.62B and trailing P/E 43.1. IPSC currently screens at market cap $47.8M.
Not investment advice. Open the IP and IPSC stock pages for the full models.
Not investment advice.